State of the Art: Personalized Antiplatelet Therapy by Genotype and Platelet Function Testing.

Gurbel PA, Jeong YH, Navarese E, Kubica J, Ramotowski B, Tantry US.

Open source

DOI
10.1002/ccd.70794
Published
2026-08-05
Container
Catheter Cardiovasc Interv
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ccd.70794,
  title = {State of the Art: Personalized Antiplatelet Therapy by Genotype and Platelet Function Testing.},
  author = {Gurbel PA and  Jeong YH and  Navarese E and  Kubica J and  Ramotowski B and  Tantry US.},
  year = {2026},
  journal = {Catheter Cardiovasc Interv},
  doi = {10.1002/ccd.70794},
  url = {https://doi.org/10.1002/ccd.70794}
}

RIS

TY  - JOUR
TI  - State of the Art: Personalized Antiplatelet Therapy by Genotype and Platelet Function Testing.
AU  - Gurbel PA
AU  -  Jeong YH
AU  -  Navarese E
AU  -  Kubica J
AU  -  Ramotowski B
AU  -  Tantry US.
PY  - 2026
JO  - Catheter Cardiovasc Interv
DO  - 10.1002/ccd.70794
UR  - https://doi.org/10.1002/ccd.70794
ER  - 

APA

PA, G., YH, J., E, N., J, K., B, R., & US., T. (2026). State of the Art: Personalized Antiplatelet Therapy by Genotype and Platelet Function Testing.. Catheter Cardiovasc Interv. https://doi.org/10.1002/ccd.70794

Source records